Expression profiling of plac1 in murine cancer cell lines

Summary. Aim: Placenta-specific 1 (PLAC1) is among recently-discovered placental antigens which exerts fundamental role in placental function and development. Increasing body of literature shows that PLAC1 is frequently activated and expressed in a wide variety of human cancers and promote cancer pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Datum:2023
Hauptverfasser: Mahmoudian, J., Ghods, R., Nazari, M., Jeddi-Tehrani, M., Ghahremani, M.H., Ostad, S.N., Zarnani, A.H.
Format: Artikel
Sprache:Englisch
Veröffentlicht: PH Akademperiodyka 2023
Schlagworte:
Online Zugang:https://exp-oncology.com.ua/index.php/Exp/article/view/2019-1-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Experimental Oncology

Institution

Experimental Oncology
_version_ 1856543541535178752
author Mahmoudian, J.
Ghods, R.
Nazari, M.
Jeddi-Tehrani, M.
Ghahremani, M.H.
Ostad, S.N.
Zarnani, A.H.
author_facet Mahmoudian, J.
Ghods, R.
Nazari, M.
Jeddi-Tehrani, M.
Ghahremani, M.H.
Ostad, S.N.
Zarnani, A.H.
author_sort Mahmoudian, J.
baseUrl_str
collection OJS
datestamp_date 2025-04-30T12:08:14Z
description Summary. Aim: Placenta-specific 1 (PLAC1) is among recently-discovered placental antigens which exerts fundamental role in placental function and development. Increasing body of literature shows that PLAC1 is frequently activated and expressed in a wide variety of human cancers and promote cancer progression. However, no data is available regarding the expression of mouse orthologue, plac1, in murine cancer cell lines. Materials and Methods: We investigated the expression of plac1 in a series of murine cell lines from different histological origins, mammary carcinoma (4T1), melanoma (B16F10), colorectal carcinoma (CT26), renal carcinoma (Renca), glioma (GL26), B-cell lymphoma (A20 and BCL1) and also two fibroblast cell lines (NIH3T3 and L929), using RT-PCR, Western blotting and flow cytometry. Results: Our data demonstrated that plac1 transcript and plac1 protein were expressed in all examined cell lines, as judged by RT-PCR and Western blot, respectively. The molecular weight of mouse plac1 was experimentally observed to be approximately 24 kD. Flow cytometric analysis showed surface expression of plac1 in aforesaid cell lines ranging from 2% to 42.5%. Conclusion: Based on the ubiquitous expression of plac1, the investigated cancer cell lines or immortalized cell lines can be used to examine the role of plac1 in the process of immortalization.
first_indexed 2025-07-17T12:17:12Z
format Article
id oai:ojs2.ex.aqua-time.com.ua:article-264
institution Experimental Oncology
language English
last_indexed 2025-07-17T12:17:12Z
publishDate 2023
publisher PH Akademperiodyka
record_format ojs
spelling oai:ojs2.ex.aqua-time.com.ua:article-2642025-04-30T12:08:14Z Expression profiling of plac1 in murine cancer cell lines Expression profiling of plac1 in murine cancer cell lines Mahmoudian, J. Ghods, R. Nazari, M. Jeddi-Tehrani, M. Ghahremani, M.H. Ostad, S.N. Zarnani, A.H. cancer, cell line, expression, immortalization, plac1 cancer, cell line, expression, immortalization, plac1 Summary. Aim: Placenta-specific 1 (PLAC1) is among recently-discovered placental antigens which exerts fundamental role in placental function and development. Increasing body of literature shows that PLAC1 is frequently activated and expressed in a wide variety of human cancers and promote cancer progression. However, no data is available regarding the expression of mouse orthologue, plac1, in murine cancer cell lines. Materials and Methods: We investigated the expression of plac1 in a series of murine cell lines from different histological origins, mammary carcinoma (4T1), melanoma (B16F10), colorectal carcinoma (CT26), renal carcinoma (Renca), glioma (GL26), B-cell lymphoma (A20 and BCL1) and also two fibroblast cell lines (NIH3T3 and L929), using RT-PCR, Western blotting and flow cytometry. Results: Our data demonstrated that plac1 transcript and plac1 protein were expressed in all examined cell lines, as judged by RT-PCR and Western blot, respectively. The molecular weight of mouse plac1 was experimentally observed to be approximately 24 kD. Flow cytometric analysis showed surface expression of plac1 in aforesaid cell lines ranging from 2% to 42.5%. Conclusion: Based on the ubiquitous expression of plac1, the investigated cancer cell lines or immortalized cell lines can be used to examine the role of plac1 in the process of immortalization. Summary. Aim: Placenta-specific 1 (PLAC1) is among recently-discovered placental antigens which exerts fundamental role in placental function and development. Increasing body of literature shows that PLAC1 is frequently activated and expressed in a wide variety of human cancers and promote cancer progression. However, no data is available regarding the expression of mouse orthologue, plac1, in murine cancer cell lines. Materials and Methods: We investigated the expression of plac1 in a series of murine cell lines from different histological origins, mammary carcinoma (4T1), melanoma (B16F10), colorectal carcinoma (CT26), renal carcinoma (Renca), glioma (GL26), B-cell lymphoma (A20 and BCL1) and also two fibroblast cell lines (NIH3T3 and L929), using RT-PCR, Western blotting and flow cytometry. Results: Our data demonstrated that plac1 transcript and plac1 protein were expressed in all examined cell lines, as judged by RT-PCR and Western blot, respectively. The molecular weight of mouse plac1 was experimentally observed to be approximately 24 kD. Flow cytometric analysis showed surface expression of plac1 in aforesaid cell lines ranging from 2% to 42.5%. Conclusion: Based on the ubiquitous expression of plac1, the investigated cancer cell lines or immortalized cell lines can be used to examine the role of plac1 in the process of immortalization. PH Akademperiodyka 2023-06-08 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2019-1-6 10.32471/exp-oncology.2312-8852.vol-41-no-1.12743 Experimental Oncology; Vol. 41 No. 1 (2019): Experimental Oncology; 7-13 Експериментальна онкологія; Том 41 № 1 (2019): Експериментальна онкологія; 7-13 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-41-no-1 en https://exp-oncology.com.ua/index.php/Exp/article/view/2019-1-6/2019-1-6 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/
spellingShingle cancer
cell line
expression
immortalization
plac1
Mahmoudian, J.
Ghods, R.
Nazari, M.
Jeddi-Tehrani, M.
Ghahremani, M.H.
Ostad, S.N.
Zarnani, A.H.
Expression profiling of plac1 in murine cancer cell lines
title Expression profiling of plac1 in murine cancer cell lines
title_alt Expression profiling of plac1 in murine cancer cell lines
title_full Expression profiling of plac1 in murine cancer cell lines
title_fullStr Expression profiling of plac1 in murine cancer cell lines
title_full_unstemmed Expression profiling of plac1 in murine cancer cell lines
title_short Expression profiling of plac1 in murine cancer cell lines
title_sort expression profiling of plac1 in murine cancer cell lines
topic cancer
cell line
expression
immortalization
plac1
topic_facet cancer
cell line
expression
immortalization
plac1
cancer
cell line
expression
immortalization
plac1
url https://exp-oncology.com.ua/index.php/Exp/article/view/2019-1-6
work_keys_str_mv AT mahmoudianj expressionprofilingofplac1inmurinecancercelllines
AT ghodsr expressionprofilingofplac1inmurinecancercelllines
AT nazarim expressionprofilingofplac1inmurinecancercelllines
AT jedditehranim expressionprofilingofplac1inmurinecancercelllines
AT ghahremanimh expressionprofilingofplac1inmurinecancercelllines
AT ostadsn expressionprofilingofplac1inmurinecancercelllines
AT zarnaniah expressionprofilingofplac1inmurinecancercelllines